EGFR and cholangiocarcinoma: The significant association of high EGFR expression on survival probability and the high sensitivity and specificity of measuring EGFR expression to identify patients at risk for a shorter survival suggests that EGFR may be a useful candidate for treatment selection in cholangiocarcinomas.